|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.05 TWD | -0.89% |
|
-5.45% | +100.77% |
| 04-19 | 3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | 3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
3D Global Biotech Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 13.64 million compared to TWD 11.08 million a year ago. Net loss was TWD 67.09 million compared to TWD 59.71 million a year ago.
Basic loss per share from continuing operations was TWD 1.22 compared to TWD 1.11 a year ago. Diluted loss per share from continuing operations was TWD 1.22 compared to TWD 1.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +100.77% | 80.09M | |
| -4.92% | 182B | |
| -3.70% | 102B | |
| -5.29% | 66.74B | |
| +10.99% | 44.89B | |
| -7.70% | 45.55B | |
| +6.13% | 40.62B | |
| +15.96% | 30.04B | |
| +14.80% | 24.34B | |
| -6.63% | 23.95B |
3D GLOBAL BIOTECH INC. 
